Meet Taylor, Director of Business at Halia Therapeutics, Inc. With a degree in Biology from Brigham Young University and an MBA from Westminster University, Taylor is a bridge between the research and business at Halia.

Halia is building a next-generation drug development model that starts with nature’s own solutions. Using the Utah Population Database, Halia’s approach turns insights from resilient individuals into powerful therapies for everyone that can protect against Alzheimer’s, cardiovascular disease, cancer and more.

Thank you Taylor for doing your part to support the life science ecosystem in Utah!